BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27476646)

  • 21. Preliminary results of a new workflow for MRI/CT-based image-guided brachytherapy in cervical carcinoma.
    Nemoto MW; Iwai Y; Togasaki G; Kurokawa M; Harada R; Kobayashi H; Uno T
    Jpn J Radiol; 2017 Dec; 35(12):760-765. PubMed ID: 29039108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
    Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
    Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Outcomes of Computed Tomography-Based Volumetric Brachytherapy Planning for Cervical Cancer.
    Simpson DR; Scanderbeg DJ; Carmona R; McMurtrie RM; Einck J; Mell LK; McHale MT; Saenz CC; Plaxe SC; Harrison T; Mundt AJ; Yashar CM
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):150-7. PubMed ID: 26130230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosimetric Comparison between Three-Dimensional Magnetic Resonance Imaging-Guided and Conventional Two-Dimensional Point A-Based Intracavitary Brachytherapy Planning for Cervical Cancer.
    Ren J; Yuan W; Wang R; Wang Q; Li Y; Xue C; Yan Y; Ma X; Tan L; Liu Z
    PLoS One; 2016; 11(9):e0161932. PubMed ID: 27611853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hybrid (CT/MRI based) vs. MRI only based image-guided brachytherapy in cervical cancer: Dosimetry comparisons and clinical outcome.
    Choong ES; Bownes P; Musunuru HB; Rodda S; Richardson C; Al-Qaisieh B; Swift S; Orton J; Cooper R
    Brachytherapy; 2016; 15(1):40-8. PubMed ID: 26602964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component.
    Fokdal L; Tanderup K; Hokland SB; Røhl L; Pedersen EM; Nielsen SK; Paludan M; Lindegaard JC
    Radiother Oncol; 2013 Apr; 107(1):63-8. PubMed ID: 23452917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brachytherapy Workflow Practices: Analysis of Different Workflow Scenarios in Patients With Cervical Cancer and Impact on IGBT Implementation-An IAEA Study.
    Ndarukwa S; Flores JA; Rosenblatt E; Berger D; Akbarov K; Hedden N; Chopra S; Hande V; Rubio AP
    JCO Glob Oncol; 2024 Feb; 10():e2300336. PubMed ID: 38386958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of high-dose-rate cervix brachytherapy applicator placement: the benefits of intraoperative ultrasound guidance.
    Davidson MT; Yuen J; D'Souza DP; Radwan JS; Hammond JA; Batchelar DL
    Brachytherapy; 2008; 7(3):248-53. PubMed ID: 18635025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of radiation doses to the para-aortic, pelvic, and inguinal lymph nodes delivered by image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Mohamed SM; Aagaard T; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
    Brachytherapy; 2015; 14(1):56-61. PubMed ID: 25176182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-dimensional high dose rate intracavitary image-guided brachytherapy for the treatment of cervical cancer using a hybrid magnetic resonance imaging/computed tomography approach: feasibility and early results.
    Beriwal S; Kannan N; Kim H; Houser C; Mogus R; Sukumvanich P; Olawaiye A; Richard S; Kelley JL; Edwards RP; Krivak TC
    Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):685-90. PubMed ID: 21908180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laminaria tent insertion in preplanning MRI for CT-based cervical cancer brachytherapy.
    Takagawa Y; Izumi S; Kita M
    Brachytherapy; 2022; 21(2):170-176. PubMed ID: 34933809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computed Tomography-Planned High-Dose-Rate Brachytherapy for Treating Uterine Cervical Cancer.
    Zolciak-Siwinska A; Gruszczynska E; Bijok M; Jonska-Gmyrek J; Dabkowski M; Staniaszek J; Michalski W; Kowalczyk A; Milanowska K
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):87-92. PubMed ID: 27375169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comprehensive evaluation of adaptive daily planning for cervical cancer HDR brachytherapy.
    Meerschaert R; Nalichowski A; Burmeister J; Paul A; Miller S; Hu Z; Zhuang L
    J Appl Clin Med Phys; 2016 Nov; 17(6):323-333. PubMed ID: 27929505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Petersen JB; Nielsen SK; Lindegaard JC; Tanderup K
    Acta Oncol; 2008; 47(7):1337-43. PubMed ID: 18663651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced toxicity with equivalent outcomes using three-dimensional volumetric (3DV) image-based versus nonvolumetric point-based (NV) brachytherapy in a cervical cancer population.
    Thomas KM; Maquilan G; Stojadinovic S; Medin P; Folkert MR; Albuquerque K
    Brachytherapy; 2017; 16(5):943-948. PubMed ID: 28602708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor and normal tissue dosimetry changes during MR-guided pulsed-dose-rate (PDR) brachytherapy for cervical cancer.
    Morgia M; Cuartero J; Walsh L; Jezioranski J; Keeler K; Xie J; Massey C; Williamson D; Cho YB; Oh S; Fyles A; Milosevic M
    Radiother Oncol; 2013 Apr; 107(1):46-51. PubMed ID: 23540555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group.
    Nag S; Cardenes H; Chang S; Das IJ; Erickson B; Ibbott GS; Lowenstein J; Roll J; Thomadsen B; Varia M;
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1160-72. PubMed ID: 15519788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parametrial boosting in locally advanced cervical cancer: combined intracavitary/interstitial brachytherapy vs. intracavitary brachytherapy plus external beam radiotherapy.
    Mohamed S; Kallehauge J; Fokdal L; Lindegaard JC; Tanderup K
    Brachytherapy; 2015; 14(1):23-8. PubMed ID: 25455382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
    Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
    Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early clinical outcomes of ultrasound-guided CT-planned high-dose-rate interstitial brachytherapy for primary locally advanced cervical cancer.
    Mesko S; Swamy U; Park SJ; Borja L; Wang J; Demanes DJ; Kamrava M
    Brachytherapy; 2015; 14(5):626-32. PubMed ID: 26024784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.